ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 102,33
0,13%
Dow Jones
39 065,26
-1,53%
DAX
18 691,32
0,05%
Brent Oil
81,31
-0,27%
Bitcoin
67 603,07
-2,17%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Onyx Pharmaceuticals, Inc. (MM) (ONXX)

  7. Onyx Pharmaceuticals, Inc. (MM) (ONXX) Actualités

ONXX

Onyx Pharmaceuticals, Inc. (MM) (ONXX)

Onyx Pharmaceuticals, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ONXX
DateHeureSourceTitreSymboleSociété
11/10/201322h46Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
02/10/201312h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/10/201322h43Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/10/201322h19Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/10/201322h14Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/10/201322h05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/10/201314h58Edgar (US Regulatory)(25-NSE)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/10/201312h34Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/10/201312h21Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/10/201312h00PR Newswire (US)Amgen Successfully Completes Onyx Pharmaceuticals Tender OfferNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
18/09/201323h30PR Newswire (US)Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of OnyxNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
17/09/201314h30MarketwiredOnyx Pharmaceuticals Announces Data Presentations at 2013 European Cancer CongressNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
10/09/201315h47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
09/09/201314h08Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
06/09/201301h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
03/09/201312h34Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
03/09/201312h08Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
30/08/201308h30PR Newswire (US)Bayer's Stivarga® (regorafenib) Tablets Approved in EuropeNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
29/08/201321h44PR Newswire (US)ONYX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiducia...NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
29/08/201301h00Business WireFaruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Onyx Pharmaceuticals, Inc. Over the Proposed Sa...NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
28/08/201310h30ZacksBull of the Day: Biogen Idec (BIIB) - Bull of the DayNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
28/08/201300h09Business WireRigrodsky & Long, P.A. Announces Investigation Of Onyx Pharmaceuticals, Inc. BuyoutNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201322h33Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201317h15Dow Jones NewsCorrection to Bayer, Onyx FDA Priority Review StoryNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201316h47PR Newswire (US)Ryan & Maniskas, LLP Announces Investigation of Onyx Pharmaceuticals, Inc.NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201313h00Dow Jones NewsBayer, Onxy Get FDA Priority Review for Sorafenib For Type of CancerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201309h15Dow Jones NewsBayer: FDA Priority Review for Nexavar Treatment of Thyroid CancerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201308h30PR Newswire (US)Bayer and Onyx Pharmaceuticals Announce FDA Priority Review Designation of Nexavar® (sorafenib) Supplemental New Drug Applic...NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201303h36PR Newswire (US)SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Ony...NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201302h38PR Newswire (US)Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareh...NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ONXX

Dernières Valeurs Consultées

COIN
AGLTETH
Agrolot Token
ASX
SGPJOP
BIT
P1X7H4
NLBNPIT1X7H4 20240619 16...
EU
BE3871294240
Belgian State Bonds
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés